| Acțiuni Insider | 14.039.011 shares |
Scorul de sentimente din interior
Insider Sentiment Score găsește companiile cumpărate de persoane din interior.
Este rezultatul unui model cantitativ sofisticat, multifactorial, care identifică companiile cu cele mai înalte niveluri de acumulare de persoane interne. Modelul de scoring folosește o combinație a numărului net de persoane din interior care cumpără în ultimele 90 de zile, totalul acțiunilor cumpărate ca procent din flota și totalul acțiunilor deținute de insider. Numărul variază de la 0 la 100, numerele mai mari indicând un nivel mai ridicat de acumulare pentru semenii săi, iar 50 fiind media.
Frecvența actualizării: zilnic
Scorul de sentiment al ofițerului
Scorul de sentiment al ofițerilor găsește companii cumpărate de ofițerii corporativi.
Prin definiție, Ofițerii Corporativi sunt Corporate Insiders, dar spre deosebire de unii dintre ceilalți Insiders (10% Acționari și Membri ai Consiliului de Administrație), Ofițerii lucrează zilnic pentru companie și își folosesc banii atunci când tranzacționează . (10% acționari și membri ai consiliului de administrație sunt adesea administratori de fonduri care gestionează banii altor persoane.) Ca atare, tranzacțiile privilegiate efectuate de către ofițeri sunt mult mai semnificative și ar trebui tratate în mod corespunzător.
La fel ca Scorul Sentimentului Insider, Scorul Sentimentului Ofițerului este rezultatul unui model cantitativ sofisticat, multifactorial, care identifică companiile cu cele mai înalte niveluri de acumulare de ofițeri.
Frecvența actualizării: zilnic
Vedeți Top Picks Insiders, care oferă o listă a companiilor cu cel mai mare sentiment din interior.
Valori cheie ale insiderului
Acest card arată modul în care compania se clasifică de-a lungul diferitelor valori interne. Clasamentul percentilei arată cum se compară această companie cu alte companii de pe piețele din SUA. Clasamentele mai înalte indică situații mai bune.
De exemplu, este în general acceptat că cumpărarea din interior este un indicator pozitiv, astfel încât companiile cu mai multe achiziții din interior s-ar clasa mai sus decât companiile cu mai puține achiziții din interior (sau chiar vânzări din interior).
Numărul net de persoane din interior care cumpără (clasament)
N/A
Numărul net de persoane din interior care cumpără este numărul total de persoane din interior care cumpără minus numărul total de persoane din interior care au vândut în ultimele 90 de zile. Rangul percentilei este afișat aici (interval de la 0 la 100%).
Procent din flota cumpărată de persoane din interior (clasament)
N/A
Procent of Float Bought by Insiders este numărul total de acțiuni cumpărate de insiders minus numărul total de acțiuni vândute de insiders în ultimele 90 de zile, împărțit la flota totală și înmulțit cu 100.
Graficul privind tranzacțiile privilegiate
Ra Pharmaceuticals, Inc. tranzacții privilegiate sunt prezentate în graficul următor. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. În general, este în general ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații materiale, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4.
Lista de persoane din interior și valori de profitabilitate
Acest tabel prezintă lista persoanelor din interior cunoscute și este generată automat din dosarele dezvăluite SEC. Pe lângă nume, cel mai recent titlu și desemnarea directorului, a ofițerului sau a proprietarului în proporție de 10%, oferim cele mai recente dețineri divulgate. În plus, atunci când este posibil, oferim performanța comercială istorică pentru persoane din interior. Performanța comercială istorică este o medie ponderată a performanței tranzacțiilor reale de cumpărare pe piață deschisă efectuate de către insider. Pentru mai multe informații despre cum se calculează, urmăriți acest webinar YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Profit mediu (%) | Acțiuni Deținut |
Despică Ajustat |
|---|
Report errors via our new Insider Auditing Tool
Înregistrări ale achizițiilor interne - Analiza profitului pe termen scurt
În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în RARX / Ra Pharmaceuticals, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție și rezultatele sunt teoretice .
Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.
Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate reprezintă acțiunile ajustate în funcție de divizarea.
Înregistrări ale vânzărilor din interior - Analiza pierderilor pe termen scurt
În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în RARX / Ra Pharmaceuticals, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție și rezultatele sunt teoretice .
Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.
Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate reprezintă acțiunile ajustate în funcție de divizarea.
Istoricul tranzactiilor
Faceți clic pe pictograma link pentru a vedea istoricul complet al tranzacțiilor. Tranzacțiile raportate ca parte a unui plan de tranzacționare automată 10b5-1 vor avea un X în coloana marcată 10b-5.
| Fişier Data |
Comerț Data |
Formă | Insider | Ticker | Titlul de securitate | Cod | Direct | Exercițiu Preț |
Unitate Preț |
Unități Schimbat |
Valoare Schimbat (1K) |
Rămas Opțiuni |
Rămas Acțiuni |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-04-03 | 2020-04-02 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | -6.135.234 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Brennan Aoife | RARX | Stock Option (Right to Buy) | D | 16,36 | -25.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Brennan Aoife | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 48,0000 | -4.858.260 | -233.196 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 22,37 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 9,90 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 2,87 | -22.857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 22,37 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 9,90 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 48,0000 | -4.858.260 | -233.196 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Restricted Stock Units | D | -30.658 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Stock Option (Right to Buy) | D | 21,00 | -107.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Stock Option (Right to Buy) | D | 6,20 | -190.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Common Stock | D | 48,0000 | -10.823 | -520 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 22,37 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 9,90 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 2,87 | -22.857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Cumbo Alexander | RARX | Stock Option (Right to Buy) | D | 12,99 | -25.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Cumbo Alexander | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Units | D | -10.416 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 21,00 | -133.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 7,33 | -62.500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 16,64 | -90.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 5,60 | -73.654 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 5,60 | -11.110 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Common Stock | D | 48,0000 | -14.492 | -696 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Restricted Stock Units | D | -9.166 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 21,00 | -107.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 7,33 | -55.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 16,64 | -67.500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 5,60 | -25.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 2,87 | -26.422 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 2,87 | -46.434 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Common Stock | D | 48,0000 | -12.595 | -605 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Restricted Stock Units | D | -4.375 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 21,00 | -107.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 7,33 | -26.250 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 16,64 | -60.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 5,60 | -31.428 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 2,87 | -30.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 2,87 | -14.285 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 0,84 | -2.857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Common Stock | D | 48,0000 | -2.973 | -143 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | -10.416 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 21,00 | -133.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 7,33 | -62.500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 16,64 | -112.500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 5,60 | -28.571 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 2,87 | -92.283 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 2,87 | -115.572 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Common Stock | D | 48,0000 | -15.622 | -750 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | -20.833 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 21,00 | -311.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 7,33 | -125.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 16,64 | -225.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 5,60 | -164.285 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 2,87 | -241.460 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 2,87 | -139.371 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Common Stock | D | 48,0000 | -234.707 | -11.266 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 22,37 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 9,90 | -15.000 | 0 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 73.654 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 11.110 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 45,1648 | -10.595 | -479 | 7.132 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2020-03-18 | 2020-03-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 44,2500 | -2.288 | -101 | 0 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 82.860 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 12.499 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,6116 | -10.595 | -494 | 7.132 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2020-01-21 | 2020-01-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 47,0200 | -2.285 | -107 | 2.288 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 92.066 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 13.888 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,9505 | -10.595 | -497 | 7.132 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 101.272 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 15.277 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 47,2252 | -10.595 | -500 | 7.132 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 46.142 | |||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 47,0821 | -10.000 | -471 | 6.234 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 47,0759 | -2.285 | -108 | 4.573 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 56.142 | |||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | COMMON STOCK | D | 46,6808 | -10.000 | -467 | 6.234 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 110.478 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 16.666 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,6559 | -10.595 | -494 | 7.132 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 119.684 | |||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 18.055 | |||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,8871 | -10.595 | -497 | 7.132 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 66.142 | |||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | COMMON STOCK | D | 46,8726 | -10.000 | -469 | 6.234 | ||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-10-17 | 2019-10-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 46,7000 | -2.285 | -107 | 6.858 | ||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 76.142 | |||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | COMMON STOCK | D | 25,4050 | -10.000 | -254 | 6.234 | ||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 128.890 | |||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 19.444 | |||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 25,2643 | -10.595 | -268 | 7.132 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 27,8949 | -2.285 | -64 | 9.143 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 138.096 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 20.833 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 27,7703 | -10.595 | -294 | 7.132 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 86.142 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | COMMON STOCK | D | 27,7703 | -10.000 | -278 | 6.234 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 96.142 | |||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 32,9479 | -10.000 | -329 | 6.234 | ||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 147.302 | |||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 22.222 | |||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 33,2870 | -4.216 | -140 | 7.132 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 32,9690 | -6.379 | -210 | 11.348 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-06-25 | 2019-06-21 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 23,7248 | -2.857 | -68 | 11.428 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 156.508 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 23.611 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 22,0439 | -7.184 | -158 | 7.132 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 21,4074 | -3.411 | -73 | 14.316 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 106.142 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 23,0906 | -414 | -10 | 6.234 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 22,2103 | -9.586 | -213 | 6.648 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-06-13 | 2019-06-11 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Heft Robert | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Brennan Aoife | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | PEARSON TIMOTHY R | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Cumbo Alexander | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Shah Rajeev M. | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Mathers Edward T | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Restricted Stock Units | D | -15.329 | 30.658 | ||||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Common Stock | D | 21,9300 | -4.506 | -99 | 10.823 | ||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Common Stock | D | 15.329 | 15.329 | ||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28.570 | ||||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28.570 | ||||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28.570 | ||||||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | -20.834 | 41.666 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 21,00 | 311.000 | 311.000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | COMMON STOCK | D | 21,0000 | -6.327 | -133 | 218.799 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | COMMON STOCK | D | 20.834 | 225.126 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Units | D | -10.417 | 20.833 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 21,00 | 133.000 | 133.000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 21,0000 | -3.285 | -69 | 7.132 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 10.417 | 10.417 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | Restricted Stock Units | D | -9.167 | 18.333 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 21,00 | 107.000 | 107.000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | COMMON STOCK | D | 21,0000 | -2.933 | -62 | 6.234 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | COMMON STOCK | D | 9.167 | 9.167 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | -10.417 | 20.833 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 21,00 | 133.000 | 133.000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | COMMON STOCK | D | 21,0000 | -3.291 | -69 | 7.126 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | COMMON STOCK | D | 10.417 | 10.417 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | King John C | RARX | Options to Purchase Common Stock | D | 21,00 | 107.000 | 107.000 | |||||
| 2018-12-14 | 2018-12-12 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 15,5000 | 1.006.452 | 15.600 | 4.858.260 | ||||
| 2018-12-14 | 2018-12-14 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 15,5000 | 645.161 | 10.000 | 6.135.234 | ||||
| 2018-12-14 | 2018-12-14 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 15,5000 | 1.006.452 | 15.600 | 4.858.260 | ||||
| 2018-11-15 | 2018-11-14 | 4 | Cumbo Alexander | RARX | Option to Purchase Common Stock | D | 12,99 | 25.000 | 25.000 | |||||
| 2018-11-01 | 2018-06-28 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 9,90 | 15.000 | 15.000 | |||||
| 2018-09-25 | 2018-09-21 | 4 | Brennan Aoife | RARX | Options to Purchase Common Stock | D | 16,36 | 25.000 | 25.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Mathers Edward T | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Shah Rajeev M. | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Bisgaard Peter | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | PEARSON TIMOTHY R | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Heft Robert | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-05-02 | 2018-05-01 | 4 | King John C | RARX | Restricted Stock Units | D | 45.987 | 45.987 | ||||||
| 2018-05-02 | 2018-05-01 | 4 | King John C | RARX | Option to Purchase Common Stock | D | 6,20 | 190.000 | 190.000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 6,0000 | 2.000.000 | 12.000 | 5.490.073 | ||||
| 2018-02-16 | 2018-02-14 | 4 | RA CAPITAL MANAGEMENT, LLC See Note | RARX | Common Stock | I | 6,0000 | 2.500.000 | 15.000 | 3.851.808 | ||||
| 2018-02-16 | 2018-02-14 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 6,0000 | 2.500.000 | 15.000 | 3.851.808 | ||||
| 2018-02-05 | 2018-02-01 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | 0,00 | 62.500 | 62.500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 7,33 | 125.000 | 125.000 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | 0,00 | 31.250 | 31.250 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 7,33 | 62.500 | 62.500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Read Simon | RARX | Restricted Stock Unit | D | 0,00 | 27.500 | 27.500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 7,33 | 55.000 | 55.000 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Unit | D | 0,00 | 31.250 | 31.250 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 7,33 | 62.500 | 62.500 | |||||
| 2017-10-30 | 2017-10-26 | 4 | Bisgaard Peter | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Lettmann Jason | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Mathers Edward T | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | PEARSON TIMOTHY R | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Shah Rajeev M. | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Heft Robert | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | RARX | Director Options to Purchase Common Stock (right to buy) | I | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-20 | 2017-06-19 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,0182 | -3.220 | -71 | 2.251.457 | ||||
| 2017-06-20 | 2017-06-16 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,2445 | -53.200 | -1.130 | 2.254.677 | ||||
| 2017-06-12 | 2017-06-08 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,0000 | -700 | -15 | 2.307.877 | ||||
| 2017-06-08 | 2017-06-07 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,1073 | -4.840 | -107 | 2.308.577 | ||||
| 2017-06-08 | 2017-06-06 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,9806 | -7.274 | -167 | 2.313.417 | ||||
| 2017-06-06 | 2017-06-05 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,1146 | -4.780 | -110 | 2.320.691 | ||||
| 2017-06-06 | 2017-06-02 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,4714 | -14.867 | -349 | 2.325.471 | ||||
| 2017-06-02 | 2017-06-01 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,8926 | -10.722 | -256 | 2.340.338 | ||||
| 2017-06-02 | 2017-05-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,9426 | -35.539 | -851 | 2.351.060 | ||||
| 2017-05-30 | 2017-05-26 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,1448 | -5.300 | -133 | 2.386.599 | ||||
| 2017-05-30 | 2017-05-25 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,0000 | -53 | -1 | 2.391.899 | ||||
| 2017-05-25 | 2017-05-24 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,0051 | -17.451 | -436 | 2.391.952 | ||||
| 2017-05-22 | 2017-05-18 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,4977 | -9.019 | -230 | 2.409.403 | ||||
| 2017-05-18 | 2017-05-17 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,5126 | -22.534 | -575 | 2.418.422 | ||||
| 2017-05-18 | 2017-05-16 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 26,3296 | -20.081 | -529 | 2.440.956 | ||||
| 2017-05-02 | 2017-03-01 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9126 | -7.778 | -163 | 2.461.037 | ||||
| 2017-05-02 | 2017-02-28 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,8577 | -7.847 | -164 | 2.468.815 | ||||
| 2017-05-02 | 2017-02-27 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9582 | -57.844 | -1.212 | 2.476.662 | ||||
| 2017-05-02 | 2017-02-24 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9336 | -5.398 | -113 | 2.534.506 | ||||
| 2017-05-02 | 2017-02-23 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,0362 | -4.999 | -105 | 2.539.904 | ||||
| 2017-05-02 | 2017-02-22 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,8553 | -749 | -16 | 2.544.903 | ||||
| 2017-02-03 | 2017-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 16,64 | 112.500 | 112.500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 16,64 | 225.000 | 225.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 16,64 | 90.000 | 90.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 16,64 | 67.500 | 67.500 | |||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Series B-2 Preferred Stock | D | -860.438 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Series B-1 Preferred Stock | D | -924.970 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 13,0000 | 246.154 | 3.200 | 2.031.562 | ||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 860.438 | 1.785.408 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 924.970 | 924.970 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series B-2 Preferred Stock | D | -3.402.729 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series B-1 Preferred Stock | D | -3.657.932 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series A Preferred Stock | D | -9.728.589 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Warrants to Purchase Common Stock | D | 0,07 | -62.914 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 13,0000 | 84.615 | 1.100 | 2.545.652 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 486.104 | 2.461.037 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 522.561 | 1.974.933 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 1.389.797 | 1.452.372 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 13,0000 | -339 | -4 | 62.575 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 0,0700 | 62.914 | 4 | 62.914 | ||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Series B-2 Preferred Stock | I | -4.015.378 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Series B-1 Preferred Stock | I | -4.316.531 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 13,0000 | 161.538 | 2.100 | 1.351.808 | ||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Common Stock | I | 573.624 | 1.190.270 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Common Stock | I | 616.646 | 616.646 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series B-2 Preferred Stock | D | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series B-1 Preferred Stock | D | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series A Preferred Stock | D | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Warrants to Purchase Common Stock | D | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 2,87 | 29.285 | 29.285 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Series B-2 Preferred Stock | I | -4.015.378 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. See footnotes | RARX | Series B-1 Preferred Stock | I | -4.316.531 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 13,0000 | 161.538 | 2.100 | 1.351.808 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 573.624 | 1.190.270 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. See footnotes | RARX | Common Stock | I | 616.646 | 616.646 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series B-2 Preferred Stock | D | -3.408.439 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series B-1 Preferred Stock | D | -3.664.071 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series A Preferred Stock | D | -9.744.916 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Warrants to Purchase Common Stock | D | 0,07 | -63.019 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 13,0000 | 263.538 | 3.426 | 2.745.846 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 486.919 | 2.482.308 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 523.438 | 1.995.389 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 1.392.130 | 1.471.951 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 13,0000 | -340 | -4 | 79.821 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 0,0700 | 63.019 | 4 | 80.161 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -481.503 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3.533.875 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -517.617 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3.798.914 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -3.408.439 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3.664.071 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series A Preferred Stock | I | -9.744.916 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Warrants to Purchase Common Stock | I | 0,07 | -63.019 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 15.633 | 203 | 4.066.503 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 114.752 | 1.492 | 4.050.870 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 263.538 | 3.426 | 3.936.118 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 68.786 | 3.672.580 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 504.839 | 3.603.794 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 73.945 | 3.098.955 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 542.702 | 3.025.010 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 486.919 | 2.482.308 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 523.438 | 1.995.389 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 1.392.130 | 1.471.951 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | -340 | -4 | 79.821 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 0,0700 | 63.019 | 4 | 80.161 | ||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34.284 | ||||||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34.284 | ||||||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34.284 | ||||||||
| 2016-10-25 | 3 | Treco Douglas A | RARX | Common Stock | D | 408.584 | ||||||||
| 2016-10-25 | 3 | Treco Douglas A | RARX | Common Stock | D | 408.584 | ||||||||
| 2016-10-25 | 3 | Lettmann Jason See footnotes | RARX | Common Stock | I | 34.284 | ||||||||
| 2016-10-25 | 3 | Lettmann Jason See footnotes | RARX | Common Stock | I | 34.284 |
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)
